May 21 |
Rezolute stock rockets 50% on Phase 2 results for eye drug RZ402
|
May 21 |
Rezolute Reports Positive Topline Results from Phase 2 Proof of Concept Study of RZ402 in Patients with Diabetic Macular Edema (DME)
|
May 16 |
Rezolute reports Q3 results
|
May 15 |
Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update
|
May 10 |
Rezolute, Inc. (NASDAQ:RZLT) has caught the attention of institutional investors who hold a sizeable 47% stake
|
Apr 23 |
Phase 2 RIZE Study Sub-Analyses to be Presented at the 2024 Pediatric Endocrine Society Annual Meeting
|
Apr 1 |
CommScope Holding And 2 Other Stocks Under $3 Insiders Are Buying
|
Mar 27 |
Rezolute Reaches US$75m Market Cap Benefiting Insider Stock Buying
|
Mar 20 |
$17M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
|
Mar 11 |
$1.5M Bet On This Penny Stock? Check Out These 4 Stocks Under $5 Insiders Are Aggressively Buying
|